Hu
thanks for that, the article I read said they were in Stage 3 trials and the drug was being trialed not only in the US but in multiple countries, have you read similar? Over here Jonathan Snake from Bell Potter and JP Morgan the perennial short selling shops have been desperately trying to keep the price down by damming with faint praise and putting ridiculously low and unsubstantiated by their evidence base price targets on the stock. Might work today, don't know about next week.
Chart Update, page-11235
-
- There are more pages in this discussion • 14,004 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.02 |
Change
0.170(2.48%) |
Mkt cap ! $5.075B | |||
| Open | High | Low | Value | Volume |
| $6.86 | $7.03 | $6.81 | $16.52M | 2.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10280 | $7.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.02 | 17972 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |